pulsed field ablation

Atlanta and Carlsbad, California, September 20, 2026 Field Medical, Inc. has announced publication of 12-month results from its first-in-human...

Caesarea, Israel, August 7, 2026 IceCure Medical has announced a significant expansion of its U.S. post-marketing clinical program with...

Nantong, China, August 7, 2026 Ractigen Therapeutics has announced a significant milestone in the development of its investigational RNA...

Nutley, New Jersey, USA, August 5, 2026 Reckitt has received U.S. Food and Drug Administration (FDA) approval for Mucinex®...

Galway, Ireland, August 6, 2026 Medtronic has secured an expanded CE Mark indication for its Affera™ Mapping and Ablation...

IRVINE, Calif., July 8, 2026 Johnson & Johnson MedTech has announced that the U.S. Food and Drug Administration (FDA)...

Irvine, California | April 24, 2026 Johnson & Johnson has announced the launch of the PERSIGMA randomized controlled trial...

Abbott Park, Illinois | April 25, 2026 Abbott has unveiled late-breaking clinical data at the Heart Rhythm Society (HRS)...

Galway, Ireland & Chicago, Illinois | April 25, 2026 Medtronic has announced significant clinical milestones for its Affera™ mapping...

IRVINE, California, United States, April 7, 2026 Johnson & Johnson MedTech announced the European launch of VARIPULSE™ Pro, an...